KEIO RESEARCHERS INFORMATION SYSTEM

Papers 【 Display / hide 】

Papers 【 Display / hide 】

• Adult cardiomyocytes-derived EVs for the treatment of cardiac fibrosis.

  Prieto-Vila M, Yoshioka Y, Kuriyama N, Okamura A, Yamamoto Y, Muranaka A, Ochiya T

  Journal of extracellular vesicles 13 ( 7 ) e12461 2024.07

  Lead author, Accepted

  • Access to Document (DOI)

• Single-Cell Transcriptome Profiling Reveals Intratumoral Heterogeneity and Molecular Features of Ductal Carcinoma In Situ.

  Tokura M, Nakayama J, Prieto-Vila M, Shiino S, Yoshida M, Yamamoto T, Watanabe N, Takayama S, Suzuki Y, Okamoto K, Ochiya T, Kohno T, Yatabe Y, Suto A, Yamamoto Y

  Cancer research 82 ( 18 ) 3236 - 3248 2022.09

  Accepted,  ISSN  0008-5472

  • Access to Document (DOI)

• Correction: Generation of human hepatic progenitor cells with regenerative and metabolic capacities from primary hepatocytes.

  Katsuda T, Matsuzaki J, Yamaguchi T, Yamada Y, Prieto-Vila M, Hosaka K, Takeuchi A, Saito Y, Ochiya T

  eLife 11 2022.08

  Accepted

  • Access to Document (DOI)

• High-grade bladder cancer cells secrete extracellular vesicles containing miRNA-146a-5p and promotes angiogenesis.

  Prieto-Vila M, Usuba W, Yoshioka Y, Takeshita F, Yoshiike M, Sasaki H, Yamamoto Y, Kikuchi E, Ochiya T

  Journal of extracellular biology 1 ( 8 ) e47 2022.08

  Lead author, Accepted

  • Access to Document (DOI)

• Biological Functions Driven by mRNAs Carried by Extracellular Vesicles in Cancer.

  Prieto-Vila M, Yoshioka Y, Ochiya T

  Frontiers in cell and developmental biology 9   620498 2021

  Lead author, Accepted,  ISSN  2296-634X

  • Access to Document (DOI)

display all >>

Presentations 【 Display / hide 】

Presentations 【 Display / hide 】

• Therapeutic potential of cardiomyocyte-derived EVs in COVID-19-induced cardiac damage and fibrosis

  [Domestic presentation] 

  2025.10

  , 

  Oral presentation (general)

• Single-cell analysis reveals a metastatic gene expression signature in a rare subpopulation of primary tumor cells

  [International presentation] 

  2025.09

  , 

  Oral presentation (general)

• Therapeutic potential of cardiomyocyte-derived EVs in COVID-19-induced cardiac damage and fibrosis

  [International presentation] 

  2025.07

  , 

  Oral presentation (invited, special)

• Cardiomyocytes-derived EVs for the treatment of cardiac fibrosis and cardiac damage

  [International presentation]  APSEV 2024, 

  2024.11

  , 

  Oral presentation (keynote)

• Cardiomyocytes-EVs improved COVID-19-derived cardiac damage and fibrosis

  [Domestic presentation]  JSEV 2024, 

  2024.10

  , 

  Poster presentation

display all >>

Research Projects of Competitive Funds, etc. 【 Display / hide 】

Research Projects of Competitive Funds, etc. 【 Display / hide 】

• Development of Cardiomyocyte-Derived Extracellular Vesicles as a Therapeutic Agent for COVID-19-Related Cardiac Inflammation and Damage

  2025.04

  -

  2028.03

  基盤研究(C), Principal investigator

Courses Taught 【 Display / hide 】

Courses Taught 【 Display / hide 】

• PRE-CLINICAL TRAINING FOR HOSPITAL & COMMUNITY PHARMACY

  2025